$CHGG
CHEGG, INC

2023 Q2 Form 10-Q Financial Statement

#000136495423000068 Filed on May 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $182.9M $187.6M $202.2M
YoY Change -6.09% -7.24% 1.95%
Cost Of Revenue $47.41M $49.15M $55.09M
YoY Change 3.78% -10.77% -22.83%
Gross Profit $135.4M $138.5M $147.2M
YoY Change -9.12% -5.92% 15.88%
Gross Profit Margin 74.07% 73.8% 72.76%
Selling, General & Admin $101.3M $95.99M $89.37M
YoY Change 13.51% 7.41% 39.45%
% of Gross Profit 74.77% 69.33% 60.73%
Research & Development $52.87M $46.91M $52.42M
YoY Change 0.75% -10.51% 13.62%
% of Gross Profit 39.04% 33.88% 35.62%
Depreciation & Amortization $26.48M $25.54M $21.81M
YoY Change 21.91% 17.14% 17.24%
% of Gross Profit 19.55% 18.45% 14.82%
Operating Expenses $154.1M $142.9M $141.8M
YoY Change 8.78% 0.79% 28.64%
Operating Profit -$18.70M -$4.446M $5.376M
YoY Change -354.61% -182.7% -67.96%
Interest Expense $9.544M $11.26M $1.477M
YoY Change 369.69% 662.56% -27.92%
% of Operating Profit 27.47%
Other Income/Expense, Net -$332.0K $10.81M $4.583M
YoY Change -272.02% 135.83% -105.79%
Pretax Income $44.29M $6.362M $9.959M
YoY Change 487.75% -36.12% -115.97%
Income Tax $19.68M $4.176M $4.217M
% Of Pretax Income 44.43% 65.64% 42.34%
Net Earnings $24.61M $2.186M $5.742M
YoY Change 229.21% -61.93% -108.81%
Net Earnings / Revenue 13.46% 1.17% 2.84%
Basic Earnings Per Share $0.21 $0.02 $0.04
Diluted Earnings Per Share $0.19 $0.02 $0.04
COMMON SHARES
Basic Shares Outstanding 119.7M shares 126.6M shares 132.2M shares
Diluted Shares Outstanding 132.9M shares 124.3M shares 133.3M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $385.1M $559.2M $1.183B
YoY Change -72.17% -52.74% -36.8%
Cash & Equivalents $136.8M $281.3M $267.7M
Short-Term Investments $209.7M $277.9M $915.4M
Other Short-Term Assets $40.99M $30.83M $14.67M
YoY Change 29.89% 110.16% -44.9%
Inventory
Prepaid Expenses $18.62M $25.49M $28.88M
Receivables $20.67M $22.00M $19.92M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $446.7M $637.5M $1.247B
YoY Change -69.23% -48.86% -35.6%
LONG-TERM ASSETS
Property, Plant & Equipment $226.6M $201.3M $187.7M
YoY Change 15.98% 7.22% 40.01%
Goodwill $629.6M $622.7M $641.3M
YoY Change 2.09% -2.9% 120.68%
Intangibles $67.63M $73.09M $102.7M
YoY Change -26.06% -28.83% 106.2%
Long-Term Investments $422.8M $613.9M $435.4M
YoY Change 59.09% 40.98% -38.78%
Other Assets $175.3M $19.82M $19.18M
YoY Change 876.45% 3.35% -25.08%
Total Long-Term Assets $1.522B $1.724B $1.416B
YoY Change 26.54% 21.79% 12.55%
TOTAL ASSETS
Total Short-Term Assets $446.7M $637.5M $1.247B
Total Long-Term Assets $1.522B $1.724B $1.416B
Total Assets $1.969B $2.362B $2.662B
YoY Change -25.84% -11.29% -16.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.95M $13.06M $9.549M
YoY Change 8.77% 36.75% -35.92%
Accrued Expenses $76.66M $68.03M $85.42M
YoY Change 10.84% -20.37% 9.39%
Deferred Revenue $53.20M $58.57M $60.46M
YoY Change -0.18% -3.13% 24.38%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $142.8M $139.7M $155.4M
YoY Change 6.28% -10.15% -38.1%
LONG-TERM LIABILITIES
Long-Term Debt $767.0M $1.190B $1.680B
YoY Change -54.37% -29.17% 0.34%
Other Long-Term Liabilities $23.68M $2.662M $6.528M
YoY Change 158.83% -59.22% -14.42%
Total Long-Term Liabilities $790.7M $1.215B $1.699B
YoY Change -53.52% -28.44% -0.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $142.8M $139.7M $155.4M
Total Long-Term Liabilities $790.7M $1.215B $1.699B
Total Liabilities $933.5M $1.355B $1.854B
YoY Change -49.15% -26.91% -4.94%
SHAREHOLDERS EQUITY
Retained Earnings -$43.76M -$68.37M -$331.4M
YoY Change -86.49% -79.37% -17.33%
Common Stock $1.122B $1.120B $1.177B
YoY Change -7.4% -4.79% -28.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.035B $1.007B $808.5M
YoY Change
Total Liabilities & Shareholders Equity $1.969B $2.362B $2.662B
YoY Change -25.84% -11.29% -16.63%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $24.61M $2.186M $5.742M
YoY Change 229.21% -61.93% -108.81%
Depreciation, Depletion And Amortization $26.48M $25.54M $21.81M
YoY Change 21.91% 17.14% 17.24%
Cash From Operating Activities $62.75M $73.16M $80.04M
YoY Change -1.53% -8.59% 8.78%
INVESTING ACTIVITIES
Capital Expenditures $16.70M $17.17M $29.53M
YoY Change -159.9% -41.88% 55.57%
Acquisitions $0.00 $401.1M
YoY Change -100.0% 4983.32%
Other Investing Activities $252.9M -$89.61M -$329.8M
YoY Change 160.41% -72.83% -55.51%
Cash From Investing Activities $236.2M -$106.8M -$363.1M
YoY Change 241.11% -70.59% -52.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $300.5M
YoY Change -127.53%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -404.9M -$158.9M -$307.5M
YoY Change -30138.35% -48.32% -135.44%
NET CHANGE
Cash From Operating Activities 62.75M $73.16M $80.04M
Cash From Investing Activities 236.2M -$106.8M -$363.1M
Cash From Financing Activities -404.9M -$158.9M -$307.5M
Net Change In Cash -105.9M -$192.3M -$585.9M
YoY Change -178.87% -67.17% -432.46%
FREE CASH FLOW
Cash From Operating Activities $62.75M $73.16M $80.04M
Capital Expenditures $16.70M $17.17M $29.53M
Free Cash Flow $46.05M $55.99M $50.50M
YoY Change -49.73% 10.87% -7.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001364954
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-36180
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CHEGG, INC
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3237489
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3990 Freedom Circle
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95054
CY2023Q1 dei City Area Code
CityAreaCode
408
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
855-5700
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
CHGG
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
119716256 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
281302000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
473677000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
277864000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
583973000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
344000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
394000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23515000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25486000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
28481000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
30832000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
34754000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
637484000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1144400000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
613863000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
216233000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
201305000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
204383000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
622679000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
615093000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
73086000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
78333000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29770000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18838000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
163776000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
167524000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19824000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20612000 usd
CY2023Q1 us-gaap Assets
Assets
2361787000 usd
CY2022Q4 us-gaap Assets
Assets
2465416000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
13058000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12367000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
58568000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
56273000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68026000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
70234000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
139652000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
138874000 usd
CY2023Q1 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1189650000 usd
CY2022Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1188593000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23064000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13375000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2662000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7985000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1215376000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1209953000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1355028000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1348827000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119628297 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119628297 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126473827 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126473827 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
120000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
126000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1120344000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1244504000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45338000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-57488000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68367000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70553000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1006759000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1116589000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2361787000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2465416000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187601000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
202244000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
49150000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
55085000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
138451000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
147159000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46907000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52415000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
37017000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
42498000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
58973000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46870000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
142897000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
141783000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4446000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5376000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1268000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1597000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12076000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6180000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10808000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4583000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6362000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9959000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4176000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4217000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5742000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123710000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132162000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124304000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133270000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5742000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3812000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-12917000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8338000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18671000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12150000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-31588000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14336000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25846000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1116589000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
151311000 usd
CY2023Q1 chgg Stock Issued During Period Value Employee Stock Purchase Plan And Stock Options Exercised
StockIssuedDuringPeriodValueEmployeeStockPurchasePlanAndStockOptionsExercised
144000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-7735000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34736000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12150000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1006759000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1106917000 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
300450000 usd
CY2022Q1 chgg Stock Issued During Period Value Employee Stock Purchase Plan And Stock Options Exercised
StockIssuedDuringPeriodValueEmployeeStockPurchasePlanAndStockOptionsExercised
455000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-7466000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34911000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31588000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5742000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
808521000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5742000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
33746000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
33084000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
25543000 usd
CY2022Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
20285000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3441000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-746000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1496000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1640000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1057000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1382000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4628000 usd
CY2023Q1 chgg Depreciation Textbook Library
DepreciationTextbookLibrary
0 usd
CY2022Q1 chgg Depreciation Textbook Library
DepreciationTextbookLibrary
1521000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-120000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-626000 usd
CY2023Q1 chgg Textbook Library Gain Loss Net
TextbookLibraryGainLossNet
0 usd
CY2022Q1 chgg Textbook Library Gain Loss Net
TextbookLibraryGainLossNet
610000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
5000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-9000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1578000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-292000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-8485000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-21722000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2803000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-8342000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-336000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7534000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2012000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8554000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2569000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7555000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6397000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2091000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
73160000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
80035000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17166000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29533000 usd
CY2023Q1 chgg Payment To Purchases Textbooks
PaymentToPurchasesTextbooks
0 usd
CY2022Q1 chgg Payment To Purchases Textbooks
PaymentToPurchasesTextbooks
3692000 usd
CY2023Q1 chgg Proceeds From Disposition Of Textbooks
ProceedsFromDispositionOfTextbooks
0 usd
CY2022Q1 chgg Proceeds From Disposition Of Textbooks
ProceedsFromDispositionOfTextbooks
2499000 usd
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
497372000 usd
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
273280000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
407759000 usd
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
342059000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
401125000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-106779000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-363072000 usd
CY2023Q1 chgg Proceeds From Issuance Of Employee Stock Purchase Plan
ProceedsFromIssuanceOfEmployeeStockPurchasePlan
145000 usd
CY2022Q1 chgg Proceeds From Issuance Of Employee Stock Purchase Plan
ProceedsFromIssuanceOfEmployeeStockPurchasePlan
456000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7736000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7467000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
151311000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
300450000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-158902000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-307461000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4628000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-192334000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-585870000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
475854000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
855893000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
283520000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
270023000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
437000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
437000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2017000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1101000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2866000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1852000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
12407000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2715000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
3941000 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
5778000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
281302000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
267731000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
63000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
70000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2155000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2222000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
283520000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
270023000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities; the disclosure of contingent liabilities at the date of the financial statements; and the reported amounts of revenues and expenses during the reporting periods. We base our estimates on historical experience, knowledge of current business conditions, and various other factors we believe to be reasonable under the circumstances. These estimates are based on management’s knowledge about current events and expectations about actions we may undertake in the future. Actual results could differ from these estimates, and such differences could be material to our financial position and results of operations.
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification of Prior Period Presentation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to conform with current period presentation, $0.7 million of deferred tax assets during the three months ended March 31, 2022 has been reclassified from other non-cash items on our condensed consolidated statements of cash flows. This change in presentation does not affect previously reported results.</span></div>
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
12400000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6388000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7875000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6625000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5940000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5515000 usd
CY2023Q1 chgg Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
1902000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
34245000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4322000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
29923000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
11263000 usd
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1477000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4628000 usd
CY2023Q1 chgg Other Miscellaneous Income Expense
OtherMiscellaneousIncomeExpense
813000 usd
CY2022Q1 chgg Other Miscellaneous Income Expense
OtherMiscellaneousIncomeExpense
75000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12076000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6180000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187601000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
202244000 usd
CY2023Q1 chgg Revenue From Contract With Customer Including Assessed Tax Increase Decrease
RevenueFromContractWithCustomerIncludingAssessedTaxIncreaseDecrease
-14643000 usd
CY2023Q1 chgg Revenue From Contract With Customer Including Assessed Tax Increase Decrease Percent
RevenueFromContractWithCustomerIncludingAssessedTaxIncreaseDecreasePercent
-0.07
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
39100000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
30900000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23515000 usd
CY2023Q1 chgg Increase Decrease In Accounts Receivable Net
IncreaseDecreaseInAccountsReceivableNet
-1515000 usd
CY2023Q1 chgg Increase Decrease In Accounts Receivable Percent
IncreaseDecreaseInAccountsReceivablePercent
-0.06
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
11505000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
11946000 usd
CY2023Q1 chgg Increase Decrease In Contract With Customer Assets
IncreaseDecreaseInContractWithCustomerAssets
-441000 usd
CY2023Q1 chgg Increase Decrease In Contract With Customer Assets Percent
IncreaseDecreaseInContractWithCustomerAssetsPercent
-0.04
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
58568000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
56273000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2295000 usd
CY2023Q1 chgg Increase Decrease In Contract With Customer Liability Percent
IncreaseDecreaseInContractWithCustomerLiabilityPercent
0.04
CY2023Q1 chgg Increase Decrease In Accounts Receivable Net
IncreaseDecreaseInAccountsReceivableNet
-1500000 usd
CY2023Q1 chgg Increase Decrease In Accounts Receivable Percent
IncreaseDecreaseInAccountsReceivablePercent
-0.06
CY2023Q1 chgg Increase Decrease In Contract With Customer Assets
IncreaseDecreaseInContractWithCustomerAssets
-400000 usd
CY2023Q1 chgg Increase Decrease In Contract With Customer Assets Percent
IncreaseDecreaseInContractWithCustomerAssetsPercent
-0.04
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2300000 usd
CY2023Q1 chgg Increase Decrease In Contract With Customer Liability Percent
IncreaseDecreaseInContractWithCustomerLiabilityPercent
0.04
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5742000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123710000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132162000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2186000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5742000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123710000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132162000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124304000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133270000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24509000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25175000 shares
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
380542000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
378042000 usd
CY2023Q1 chgg Available For Sale Securities Debt Maturities Year One Through Two Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesYearOneThroughTwoAmortizedCostBasis
612822000 usd
CY2023Q1 chgg Available For Sale Securities Debt Maturities Year One Through Two Fair Value
AvailableForSaleSecuritiesDebtMaturitiesYearOneThroughTwoFairValue
613863000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
149731000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
149731000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1143095000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1141636000 usd
CY2022Q2 chgg Stock Repurchase Program Increase Of Authorized Amount
StockRepurchaseProgramIncreaseOfAuthorizedAmount
1000000000 usd
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
2000000000 usd
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
492600000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33746000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33084000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1000000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1800000 usd

Files In Submission

Name View Source Status
0001364954-23-000068-index-headers.html Edgar Link pending
0001364954-23-000068-index.html Edgar Link pending
0001364954-23-000068.txt Edgar Link pending
0001364954-23-000068-xbrl.zip Edgar Link pending
chgg-20230331.htm Edgar Link pending
chgg-20230331.xsd Edgar Link pending
chgg-20230331_g1.jpg Edgar Link pending
ex31012023-3x31.htm Edgar Link pending
ex31022022-3x31.htm Edgar Link pending
ex32012023-03x31.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
chgg-20230331_cal.xml Edgar Link unprocessable
chgg-20230331_pre.xml Edgar Link unprocessable
chgg-20230331_lab.xml Edgar Link unprocessable
chgg-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chgg-20230331_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending